2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1336144575 MD
Verify on CMS →

KARINA FINDLAY, MD

Retina Specialist (Ophthalmology) Physician in TAMPA, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
228
Medicare Part D claims · 67 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$934.16
15 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: KARINA FINDLAY, MD is a Retina Specialist (Ophthalmology) Physician ([object Object]) practicing in TAMPA, Florida with a Medicare Part D prescribing footprint of 228 claims across 67 beneficiaries — 41% brand-name prescribing . Their CMS MIPS Final Score of 100/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $934.16 across 15 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: KARINA FINDLAY, MD reported a CMS MIPS final score of 100 out of 100, above the 83.1 national average, and filed 228 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

KARINA FINDLAY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

KARINA FINDLAY, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 06/15/2005

NPI 1336144575

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

228 59% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Retina Specialist (Ophthalmology) Physician compares to other specialties among Florida providers

Florida providers

Retina Specialist (Ophthalmology) Physician share within Florida

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within Florida

Medicare quality performance — MIPS

KARINA FINDLAY, MD's 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KARINA FINDLAY, MD is a Retina Specialist (Ophthalmology) Physician provider practicing in TAMPA, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1336144575. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

KARINA FINDLAY, MD appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding MD credentials at 2705 W SAINT ISABEL ST, TAMPA, FL, 33607, with a listed phone of (813) 879-5795. NPI 1336144575 was issued on 06/15/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FINDLAY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 228 prescription claims written by this provider, covering 67 Medicare beneficiaries and totaling roughly $25K in drug spend, split 41% brand-name and 59% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2705 W SAINT ISABEL ST
TAMPA, FL 33607

Provider Details

NPI 1336144575
Specialty Retina Specialist (Ophthalmology) Physician
Credentials MD
Gender Female
NPI Issued 06/15/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where KARINA FINDLAY, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PAUTLER COHEN FINDLAY EICHENBAUM WHITE AND CRANE MDS PA
TAMPA, FL
TAMPA EYE CLINIC AND ASSOCIATES PA
TAMPA, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KARINA FINDLAY, MD. Source: openpaymentsdata.cms.gov.

Total received

$934

Largest payer

Regeneron Healthcare Solutions, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to KARINA FINDLAY, MD. To verify KARINA FINDLAY, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

KARINA FINDLAY, MD — brand share 41.0%
Specialty average (est.)

41% brand-name claims vs 59% generic, on 228 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

228
Total Claims
$25K
Total Drug Cost
67
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
311
Total Day Supply
8,097
Brand vs Generic
41% brand / 59% generic
Brand Drug Cost
$20K
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
74.6 years
Avg HCC Risk Score
1.61
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ketorolac Tromethamine
64
Prednisolone Acetate
61
Atropine Sulfate
11
Dorzolamide Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How KARINA FINDLAY, MD fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

KARINA FINDLAY, MD's 228 claims are below the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as FINDLAY.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KARINA FINDLAY, MD's specialty?
KARINA FINDLAY, MD specializes in Retina Specialist (Ophthalmology) Physician and practices in TAMPA, Florida. Credentials: MD.
How much does KARINA FINDLAY, MD prescribe under Medicare Part D?
In 2023, KARINA FINDLAY, MD wrote 228 Medicare Part D claims totaling $25K in drug costs for 67 beneficiaries.
What is KARINA FINDLAY, MD's Medicare quality score?
KARINA FINDLAY, MD has a CMS MIPS Final Score of 100/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is KARINA FINDLAY, MD located?
KARINA FINDLAY, MD is located at 2705 W SAINT ISABEL ST, TAMPA, FL, 33607. Phone: (813) 879-5795.
What is KARINA FINDLAY, MD's NPI number?
KARINA FINDLAY, MD's National Provider Identifier (NPI) is 1336144575, issued on 06/15/2005.
Does KARINA FINDLAY, MD prescribe more brand-name or generic drugs?
KARINA FINDLAY, MD's prescribing is 41% brand-name and 59% generic drugs by claim count, with $20K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does KARINA FINDLAY, MD prescribe most often?
Based on 2023 Medicare Part D data, KARINA FINDLAY, MD's most frequently prescribed drugs include Ketorolac Tromethamine, Prednisolone Acetate, Atropine Sulfate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KARINA FINDLAY, MD accept Medicare?
KARINA FINDLAY, MD appears in CMS Medicare data with 228 Part D claims and 67 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KARINA FINDLAY, MD's credentials?
KARINA FINDLAY, MD's NPI is 1336144575 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology